[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100537492":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":25,"centralContacts":29,"locations":39,"responsibleParty":69,"collaborators":7,"id":72,"slug":73,"hasResults":74,"nctId":75,"briefTitle":76,"officialTitle":77,"acronym":7,"eligibilityCriteria":78,"healthyVolunteers":74,"sex":79,"minAge":80,"maxAge":81,"enrollmentInfo":82,"targetDuration":7,"studyType":85,"phases":7,"briefSummary":86,"conditions":87,"keywords":92,"overallStatus":42,"whyStopped":7,"lastUpdateSubmitDate":94,"lastUpdatePostDateStruct":95,"startDateStruct":98,"completionDateStruct":100,"leadSponsor":102,"locationsCount":103},{"fullName":5,"class":6},"Lithuanian University of Health Sciences","OTHER",null,[9,15,20],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":13},"DIAGNOSTIC_TEST","Brief Negative Symptoms Scale","The Lithuanian Brief Negative Symptoms scale (BNSS) version will be used and validated. BNSS is used as a modern tool for the evaluation of negative symptoms of schizophrenia. Older tools used for negative symptoms evaluation often include symptoms from other dimensions of symptoms of schizophrenia, and BNSS evaluates negative symptoms specifically. BNSS is a semi-structured interview made of 13 items. There are six subscales: anhedonia (3 items), lack of normal distress (1 item), asociality (2 items), avolition (2 items), blunted affect (3 items) and alogia (2 items).",[14],"BNSS",{"type":10,"name":16,"description":17,"armGroupLabels":7,"otherNames":18},"The Calgary Depression Scale for Schizophrenia","The Lithuanian version of the CDSS will be used and validated. CDSS is a tool used to evaluate depressive symptoms, specifically for patients with schizophrenia. Often, distinguishing between depressive and negative symptoms of schizophrenia is difficult. Therefore, it is recommended to use tools designed specifically for patients with schizophrenia. CDSS is the only depression scale designed to assess depression in people with a schizophrenia syndrome disorder. It is a semi-structured interview consisting of 9 items.",[19],"CDSS",{"type":10,"name":21,"description":22,"armGroupLabels":7,"otherNames":23},"The Schizophrenia Cognition Rating Scale","The Lithuanian version of the SCoRS will be used and validated. SCoRS is a 20-item interview-based assessment tool that evaluates cognitive deficits and the degree to which these deficits impair specifically in patients with schizophrenia.",[24],"SCoRS",[26],{"name":27,"affiliation":5,"role":28},"Virginija Adomaitienė, Prof.","PRINCIPAL_INVESTIGATOR",[30,35],{"name":31,"role":32,"phone":33,"phoneExt":7,"email":34},"Jonas Montvidas, MD","CONTACT","+37066240919","jonas.montvidas@lsmu.lt",{"name":36,"role":32,"phone":37,"phoneExt":7,"email":38},"Algirdas Musneckis, MD","+37061378748","algirdas.musneckis@kaunoklinikos.lt",[40,60],{"facility":41,"status":42,"city":43,"state":7,"zip":44,"country":45,"countryCode":46,"cosmosGeoPoint":47,"geoPoint":52,"contacts":53},"Lithuanian University of Health Sciences Hospital Kaunas Clinics","RECRUITING","Kaunas","LT-50161","Lithuania","LT",{"type":48,"coordinates":49},"Point",[50,51],23.90909,54.90156,{"lat":51,"lon":50},[54,56],{"name":55,"role":32,"phone":33,"phoneExt":7,"email":34},"Jonas Montvidas",{"name":57,"role":32,"phone":58,"phoneExt":7,"email":59},"Eimantas Zauka","+37069220076","eimantas.zauka@kaunoklinikos.lt",{"facility":55,"status":42,"city":43,"state":7,"zip":61,"country":45,"countryCode":46,"cosmosGeoPoint":62,"geoPoint":64,"contacts":65},"LT-53137",{"type":48,"coordinates":63},[50,51],{"lat":51,"lon":50},[66,67],{"name":55,"role":32,"phone":33,"phoneExt":7,"email":34},{"name":68,"role":32,"phone":37,"phoneExt":7,"email":38},"Algirdas Musneckis",{"type":28,"investigatorFullName":70,"investigatorTitle":71,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"Virginija Adomaitienė","Head of Psychiatry Department","100537492","validation-of-the-lithuanian-version-of-the-bnss-cdss-and-the-scors-100537492",false,"NCT06278532","Validation of the Lithuanian Version of the BNSS, CDSS, and the SCoRS","Validation of the Lithuanian Version of the Brief Negative Symptoms Scale, Calgary Depression Scale for Schizophrenia, and the Schizophrenia Cognition Rating Scale","Inclusion Criteria:\n\n* age 18 - 65 years old;\n* Diagnosis of F20, F25 or F21 according to ICD-10;\n* Signed informed consent form.\n\nExclusion Criteria:\n\n* Age younger than 18 or older than 65 years old;\n* Did not sign the informed consent form;\n* Legally inactive person\n* Patients with a comorbid or primary diagnosis of mental retardation according to ICD-10 (F70 - F79);\n* Patients with a comorbid or primary diagnosis of mental and behavioural disorders due to psychoactive substance use (F10 - F19)\n* Patients with a comorbid of primary diagnosis of organic, including symptomatic, mental disorders (F00 - F09)","ALL","18 Years","65 Years",{"count":83,"type":84},200,"ESTIMATED","OBSERVATIONAL","This study aims to validate the Lithuanian version of the Brief Negative Symptoms Scale, Calgary Depression Scale for Schizophrenia, and Schizophrenia Cognition Rating Scale in a Lithuanian sample. This will be done by comparing results obtained from the Brief Negative Symptoms Scale, Calgary Depression Scale for Schizophrenia, and Schizophrenia Cognition Rating Scale with results obtained from the Positive and Negative Symptoms Scale, the Montgomery Asberg Depression Rating Scale, and the Montreal Cognitive Assessment test.",[88,89,90,91],"Schizophrenia","Negative Symptoms in Schizophrenia","Depressive Symptoms Due to Primary Psychotic Disorder (Diagnosis)","Cognitive Deficit",[93],"Schizophrenia, Negative symptoms, Depressive symptoms of Schizophrenia, Cognitive deficits of Schizophrenia","2024-02-19",{"date":96,"type":97},"2024-02-26","ACTUAL",{"date":99,"type":97},"2023-12-11",{"date":101,"type":84},"2026-12-11",{"name":5,"class":6},2]